AJP - Heart and Circulatory Physiology, Vol 256, Issue 6 1747-H1751, Copyright © 1989 by American Physiological Society

ARTICLES

Central effect of endothelin on blood pressure in conscious rats

Y. Ouchi, S. Kim, A. C. Souza, S. Iijima, A. Hattori, H. Orimo, M. Yoshizumi, H. Kurihara and Y. Yazaki
Department of Geriatrics, Faculty of Medicine, University of Tokyo, Japan.

This study was conducted to investigate the effect of intracerebroventricular administration of endothelin (EDT), a novel potent vasoconstricting peptide, on blood pressure in conscious rats. The lateral cerebral ventricle of male Wistar rats was cannulated, and the femoral artery was also cannulated to measure the mean arterial blood pressure (MABP) and heart rate (HR). EDT dissolved in 10 microliters of artificial cerebrospinal fluid (ACSF) (8.25-66 pmol icv) provoked a dose-dependent increase in MABP. EDT also increased HR, although the effect of 66 pmol was variable. Intracerebroventricular ACSF did not provoke any effects on MABP and HR. Intracerebroventricular EDT also provoked contralateral rotational behavior. Pretreatment with 2 mg/kg iv phenoxybenzamine significantly suppressed the 16.5 pmol icv EDT-induced increase in MABP. Moreover, 16.5 pmol icv EDT markedly increased plasma epinephrine and norepinephrine concentration. These results indicate that EDT has a central pressor action, and the action might be mediated, at least in part, by catecholamine release to the periphery. EDT might play a role in the central control of blood pressure, although the physiological implications have not yet been determined.

This article has been cited by other articles:

				A. W. C. Yip and T. L. Krukoff Endothelin-A receptors and NO mediate decrease in arterial pressure during recovery from restraint Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R881 - R889. [Abstract] [Full Text] [PDF]

				N. F. Rossi and H. Chen PVN lesions prevent the endothelin 1-induced increase in arterial pressure and vasopressin Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E349 - E356. [Abstract] [Full Text] [PDF]

				G. Grassi, G. Seravalle, R. Dell'Oro, C. Turri, G. B. Bolla, and G. Mancia Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension Hypertension, October 1, 2000; 36(4): 538 - 542. [Abstract] [Full Text] [PDF]

				Y. Kurihara, H. Kurihara, H. Morita, W.-H. Cao, G.-Y. Ling, M. Kumada, S. Kimura, R. Nagai, Y. Yazaki, and T. Kuwaki Role of endothelin-1 in stress response in the central nervous system Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R515 - R521. [Abstract] [Full Text] [PDF]

				N. F. Rossi, D. S. O'Leary, D. Woodbury, and H. Chen Endothelin-1 in hypertension in the baroreflex-intact SHR: a role independent from vasopressin release Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E18 - E24. [Abstract] [Full Text] [PDF]

				J.-C. le Mevel, C. Delarue, D. Mabin, and H. Vaudry Central and peripheral administration of endothelin-1 induces an increase in blood pressure in conscious trout Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1010 - R1017. [Abstract] [Full Text] [PDF]

				D. H. Damon Postganglionic sympathetic neurons express endothelin Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R873 - R878. [Abstract] [Full Text] [PDF]

				E. R. Levin Endothelins N. Engl. J. Med., August 10, 1995; 333(6): 356 - 363. [Full Text] [PDF]

				R. Mosqueda-Garcia, K. Yates, J. O'Leary, and T. Inagami Cardiovascular and Respiratory Effects of Endothelin in the Ventrolateral Medulla of the Normotensive Rat Hypertension, August 1, 1995; 26(2): 263 - 271. [Abstract] [Full Text]

				S. Aharinejad, D. E. Schraufnagel, A. Miksovsky, E. K. Larson, and S. C. Marks Jr. Endothelin-1 focally constricts pulmonary veins in rats J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 148 - 156. [Abstract] [Full Text]

				M. D'Amico, L. Berrino, S. Maione, A. Filippelli, A. Pizzirusso, S. Vitagliano, and F. Rossi Endothelin-1 in Rat Periaqueductal Gray Area Induces Hypertension Via Glutamatergic Receptors Hypertension, April 1, 1995; 25(4): 507 - 510. [Abstract] [Full Text]

				S. A. Douglas, M. Gellai, M. Ezekiel, G. Z. Feuerstein, J. D. Elliott, and E. H. Ohlstein Antihypertensive Actions of the Novel Nonpeptide Endothelin Receptor Antagonist SB 209670 Hypertension, April 1, 1995; 25(4): 818 - 822. [Abstract] [Full Text]